Editorial
Does bisphosphonate treatment reduce the risk of future cancer?
Abstract
Bisphosphonates are the first line of treatment for osteoporosis and metastatic bone cancer. It is almost fifty years since their antiresorptive properties were described and subsequently were used clinically.
